| Randy Dee Hassler, MD | |
|
501 S Santa Fe Ave, Ste 380, Salina, KS 67401-4189 | |
| (785) 827-9635 | |
| (785) 827-6697 |
| Full Name | Randy Dee Hassler |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 501 S Santa Fe Ave, Salina, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225011661 | NPI | - | NPPES |
| 100081570A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 0417849 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Randy Dee Hassler, MD 501 S Santa Fe Ave, Ste 380, Salina, KS 67401-4189 Ph: (785) 827-9635 | Randy Dee Hassler, MD 501 S Santa Fe Ave, Ste 380, Salina, KS 67401-4189 Ph: (785) 827-9635 |
News Archive
Scientists at The Scripps Research Institute have used a powerful new chemical-screening method to find compounds that inhibit the activity of human immunodeficiency virus (HIV), the virus that causes AIDS.
Clemson University bioengineer Karen Burg and her colleagues in the Institute for Biological Interfaces of Engineering are developing a new, integrative means of studying the complex behavior of cancer cells in breast tissue that may one day change the way doctors treat the disease.
Fourteen states this year are facing federal budgetary shortfalls for SCHIP because of inflation, higher enrollment levels and program expansions, USA Today reports. Democratic lawmakers want to provide an additional $745 million through a bill funding the Iraq war to maintain coverage levels through the end of this fiscal year.
A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer shows potent preclinical immune responses -; including several that distinguish it from other COVID-19 vaccine approaches -; according to a preprint deposited in the BioRxiv repository this week.
Hubrecht Organoid Technology (HUB), and the health insurance companies CZ, Zilveren Kruis, and Menzis announced today that they will start a €3 million validation trial for use of HUB Organoid Technology to test if it can be used to determine the response of Cystic Fibrosis (CF) patients to new drug therapies.
› Verified 7 days ago
William Dee Mauch, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 218 S Santa Fe Ave, Salina, KS 67401 Phone: 785-827-9635 Fax: 785-827-6697 | |
Donald Allen Shrader, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 501 S Santa Fe Ave, Suite 380, Salina, KS 67401 Phone: 785-827-9635 Fax: 785-827-6697 | |
Dr. Michael Joseph Matteucci Sr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 218 S Santa Fe Ave, Salina, KS 67401 Phone: 785-827-9635 | |
Dr. Ryan Adam Payne, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 218 S Santa Fe Ave, Salina, KS 67401 Phone: 785-827-9635 Fax: 785-827-6697 | |
Brian Glen Smith, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 218 S Santa Fe Ave, Salina, KS 67401 Phone: 785-827-9635 Fax: 785-827-6697 |